Rheumatoid Arthritis

• CLINICAL_TRIALS trial_result · 2016-11-09
  Clinical Trial Update: A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs [Phase 3]

  Phase 3 study evaluating tocilizumab in combination with DMARDs for moderate-to-severe rheumatoid arthritis with inadequate response to DMAR…

• CLINICAL_TRIALS trial_result · 2016-11-07
  Clinical Trial Update: A Study of ARRY-438162 in Patients With Rheumatoid Arthritis [Phase 2]

  Phase 2 trial update for ARRY-438162 in rheumatoid arthritis has completed with results posted in 2016.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis [Phase 3]

  Clinical trial update describing the completion of a Phase 3 study evaluating the safety and efficacy of tocilizumab in patients with active…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy [Phase 3]

  A Phase 3 study evaluating the addition of tocilizumab to methotrexate in adults with moderate to severe active rheumatoid arthritis already…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis [Phase 2]

  Phase 2 trial comparing MLTA3698A plus a DMARD versus Adalimumab plus a DMARD in active rheumatoid arthritis has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis [Phase 1]

  Phase 1 study evaluating subcutaneously administered tocilizumab in rheumatoid arthritis has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

  An observational study evaluating fatigue in patients with rheumatoid arthritis treated with tocilizumab (RoActemra/Actemra) has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

  An observational study of rheumatoid arthritis patients treated with tocilizumab (RoActemra/Actemra) has completed enrollment and aims to as…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

  An observational study of RoActemra/Actemra (tocilizumab) in patients with moderate to severe rheumatoid arthritis has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

  An observational study evaluating outcomes in patients with rheumatoid arthritis treated with MabThera (rituximab) has completed.

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids

  This completed observational study assesses the use of tocilizumab (RoActemra/Actemra) in rheumatoid arthritis patients who are receiving gl…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)

  This clinical trial update reports an observational study assessing glucocorticoid use in rheumatoid arthritis patients treated with tociliz…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

  This completed retrospective observational study evaluated adherence to RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthriti…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]

  Phase 3 study evaluating tocilizumab in combination with DMARD therapy for moderate-to-severe rheumatoid arthritis; the trial status is comp…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)

  This is a completed observational study evaluating the safety and effectiveness of tocilizumab in combination with methotrexate for rheumato…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)

  This update summarizes completion of a local, non-interventional study in Poland assessing first-line use of RoActemra (tocilizumab) for rhe…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)

  An observational trial evaluating Rituximab in active rheumatoid arthritis patients with inadequate response to anti-TNF therapy has been te…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis

  An observational study evaluating smoking vs. non-smoking rheumatoid arthritis patients treated with tocilizumab (RoActemra/Actemra) has com…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis

  This update reports the completion of a non-interventional observational study evaluating tocilizumab (RoActemra/Actemra) in patients with r…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

  An observational study of tocilizumab (RoActemra/Actemra) in rheumatoid arthritis patients who had an inadequate response to DMARDs has comp…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. [Phase 4]

  A Phase 4 trial evaluating MabThera (rituximab) in rheumatoid arthritis patients who had an inadequate response to a single anti-TNF inhibit…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926 [Phase 3]

  This entry covers a long-term extension study of tocilizumab (RoActemra/Actemra) in patients with early moderate to severe rheumatoid arthri…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

  This update reports that the non-interventional MONACO study evaluating tocilizumab as monotherapy in rheumatoid arthritis has been terminat…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

  This document reports an observational study of tocilizumab (RoActemra/Actemra) used in patients with rheumatoid arthritis. The study has co…

• CLINICAL_TRIALS trial_result · 2016-11-02
  Clinical Trial Update: SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. [Phase 4]

  This document reports that the Phase 4 SWITCH trial in rheumatoid arthritis patients who failed an initial TNF-blocking therapy has complete…